Studies on ANGPTL2 have shown that it can contribute to colorectal cancer cell proliferation, migration, and invasion, promote CRC cell survival after anti-neoplastic drug treatment (by regulating anti-apoptotic BCL-2 family genes), and develop resistance to chemotherapy. This evidence concerns the gene ANGPTL2 and colorectal carcinoma.